Clinical trial
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent…
NCT00345358 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00345358 |
|---|---|
| Title | Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine |
| Official title | Evaluate Immunogenicity, Safety & Reactogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine Given as Catch-up Immunization in Children Older Than 7 mo of Age or as 3-dose Primary Immunization in Children Before 6 mo of Age |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infections, Streptococcal |
| Intervention type | Biological |
| Interventions | Synflorix, Infanrix IPV/Hib |
| Enrollment | 600 |
| Start date | Sep 18, 2006 |
| Primary completion | Nov 15, 2007 |
| Completion | Nov 15, 2007 |
| First posted | Jun 28, 2006 |
| Last update posted | Jan 15, 2019 |
| Countries | Finland |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: